Cargando…
Investigation of a Thromboxane A(2) Receptor–Based Vaccine for Managing Thrombogenesis
BACKGROUND: Despite the well‐established role for the thromboxane A(2) receptor (TPR) in the development of thrombotic disorders, none of the antagonists developed to date has been approved for clinical use. To this end, we have previously shown that an antibody targeted against TPR's ligand‐bi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064912/ https://www.ncbi.nlm.nih.gov/pubmed/29936414 http://dx.doi.org/10.1161/JAHA.118.009139 |